Navigation Links
Exhaustive Study to Expand the Efficacy of Drug L-dopa for Parkinson's

Parkinson's sufferers are usually treated with the drug called levodopa or L-dopa that helps in reviving cellular communication//. After prolonged use of the drug, many patients may experience motor complications and a reduced response to the drug.

Parkinson's disease is a slow process of destruction of brain cells which produce dopamine. As dopamine levels fall, the symptoms of Parkinson’s shows up as tremors in the arms, legs and face. The patients visibly portray slow movement, lack of proper balance and coordination.

A new clinical trial is underway to evaluate the effectiveness of a novel drug to treat Parkinson’s, which could extend the benefits of he existing drug, L-dopa. The study will also investigate the potential of the drug, E2007, and its contribution in extending the effectiveness of L-dopa.

The prevailing treatment for Parkinson's disease aims to revive cellular communication by simply restoring the lost dopamine with L-dopa. Though this therapy is effective for sometime, yet it is unable to halt the gradual decline so evident in long time Parkinson’s sufferers.

"The hope is that by altering dopamine transmission through the modulating the activity of AMPA receptors, there will be measurable effects on the dopamine system," said Dr. Liang.

The study has been tailored to suit patients suffering advanced Parkinson's and have been undergoing L-dopa treatment for a considerable period of time. The study will involve nearly 700 patients from more than 100 centers across the U.S., Canada, Australia, New Zealand and South America.

Dr. Kremens said, "It's an interesting approach and an exciting trial because it is exploring a drug in a new therapeutic category. L-dopa is still the gold standard and we haven't come up with a better dopamine as yet."
'"/>




Page: 1

Related medicine news :

1. Dolly Paves the Way for Exhaustive Stem Cell Research
2. Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively
3. Tomato Sauce reduces Cancer Risk- Study
4. Study on obesity and heart failure
5. National Lung Study in the process
6. Study casts doubt on keyboard ills
7. Study reveals how stress can make you sick
8. Study reveals how stress can make you sick
9. Study supports vegetable diet
10. Study to look at early surgery to treat epilepsy
11. Its Never Too Late to Stop Smoking,Study Finds
Post Your Comments:
(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...econd largest AIDS capital in the United States. T...ics//. However its been found that primary care pr... are often failing to offer either HIV testing or ...a new UCLA AIDS Institute study. Hence AIDS cases ...
...chronic diseases], more people can live longer.'Ra...vent and treat diseases are bringing// closer the ...tential to live 100 years or longer, said Dr. Pasc...ty of Miami Miller School of Medicine. ''In five ...
...wmakers -- including Sens. Debbie Stabenow (D-Mich... Cubin (R-Wyo.) and Lois Capps (D-Calif.) -- earli...1014) that aims to improve heart disease education...d increase women's access to heart disease screeni...
...t study, the ages at which teenagers and children ...e a significant impact on their delinquent behavio... is a case of first intercourse earlier than their...was published in February edition of the Journal o...
Other Medicine News:Health News:Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests 2Health News:Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests 3Health News:Genetics Might Engineer Path to Successful Aging 2
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Susan G. Komen for th...n unprecedented $100,million in grants to American...ast track breast cancer research. Grants were also... from the Barbara Ann Karmanos Cancer Institute an... Boerner, Ph.D., assistant,professor, and Guojun W...
(Date:10/14/2008)...t. 10 /- Regado Biosciences, Inc.,an... in the Phase IIa,clinical study of its REG1 Antic...percutaneous coronary intervention (PCI). REG1 is ...d anticoagulant, RB006, and its matched,active re...nd neutralizes,RB006. The Phase IIa study (REVERSA...
(Date:10/13/2008)... million dollar NIH funding advances study S... rates, MINNEAPOLIS, Oct. 13 /- Adva...edcirculatory.com ) announced today that it has re...the National Institutes of,Health (NIH) to continu...on,those who experience cardiac arrest outside a h...
(Date:10/13/2008)...nnounce Interim Results in January 2009 and Final ..., EMERYVILLE, Calif., Oct. 13 /PRNewswire-FirstCa... (Nasdaq: NTII ) today announced that following a...n to discuss the,Viprinex(TM) (ancrod) Phase 3 cli...ny plans to consolidate and analyze data from its ...
Breaking Medicine Technology:Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 2Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 3Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 4Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 5Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 2Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4Before Every Surgery Take a TIME OUT 28R 29 5745 1Before Every Surgery Take a TIME OUT 28R 29 5745 2Black Athletes Hearts May Differ From Those of Whites 20899 1Black Athletes Hearts May Differ From Those of Whites 20899 2Black Athletes Hearts May Differ From Those of Whites 20899 3Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 1Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 1Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 3Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 4
...ated for the treatment of plantar fasciitis and Ac...ply. The splint features adjustable dorsiflexion a... nightly contractures and tightening of the planta... flexibility in the treatment of the problem by al...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
... compression and cold, the Foot Cryo/Cuff minimize...ly designed cuff provides complete foot coverage f...ed as a single cuff, or with a cooler (including a... available separately and can be used with any mod...
Medicine Products: